Cencora (COR) vs Cosmos Health (COSM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cosmos Health (COSM) has outperformed Cencora (COR) over the past year, gaining 314.5% versus a loss of 7.3%. Over five years, COR leads with a +182.0% price change compared with -17.6% for COSM. Cencora is the larger company by market cap ($64.71 billion vs $14.1 million), about 4576.5 times the size, while Cosmos Health is growing revenue faster (+19.9% vs +9.3%).
On valuation, Cencora trades at a lower forward P/E (15.6x vs 40.1x for Cosmos Health). Cencora pays a dividend yielding 0.71%, while Cosmos Health does not currently pay one. Cencora converts more of its revenue into profit, with a net margin of 0.5% versus -29.3%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COR | COSM |
|---|---|---|
| Share price | $339.09 | $2.81 |
| Market cap | $64.71B | $14.14M |
| 1-day change | -0.63% | -2.09% |
| YTD return | +0.40% | +464.26% |
| 1-year return | -7.27% | +314.45% |
| 5-year return | +182.03% | -17.60% |
| P/E ratio (TTM) | 18.89 | — |
| Forward P/E | 15.60 | 40.14 |
| EPS (TTM) | $17.95 | $-13.00 |
| Dividend yield | 0.71% | 0.00% |
| Annual dividend | $2.40 | $0.00 |
| Revenue (latest FY) | $321.33B | $65.27M |
| Revenue growth (YoY) | +9.31% | +19.93% |
| Net income (latest FY) | $1.55B | $-19.14M |
| Gross margin | 3.57% | 12.10% |
| Operating margin | 0.82% | -25.59% |
| Net margin | 0.48% | -29.33% |
| 52-week high | $377.54 | $14.36 |
| 52-week low | $244.82 | $2.20 |
| Distance from 52-week high | -10.18% | -80.43% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +12.78% | +60.14% |
| Average volume | 1.29M | 163.51K |
| Shares outstanding | 190.83M | 5.03M |
| Employees | 47,000 | 163 |
| Sector | Health Care | Health Care |
| Industry | Other Pharmaceuticals | Other Pharmaceuticals |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Cencora is about 4576.5 times larger than Cosmos Health by market value ($64.71B vs $14.14M).
- COSM has outperformed COR by 321.7 percentage points over the past year.
- Cencora is more profitable, keeping 0.5 cents of every revenue dollar as net income versus -29.3 cents for Cosmos Health.
- Cosmos Health grew revenue faster in its latest fiscal year (+19.93% vs +9.31%).
About Cencora
COR stock →Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.
Health Care · Other Pharmaceuticals · 47,000 employees
About Cosmos Health
COSM stock →Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus.
Health Care · Other Pharmaceuticals · 163 employees
COR vs COSM FAQ
Which is bigger, Cencora or Cosmos Health?
Cencora (COR) is larger, with a market capitalization of $64.71B compared with $14.14M for Cosmos Health (COSM).
Which stock has performed better over the past year, COR or COSM?
COSM returned +314.45% over the past 12 months, compared with -7.27% for COR (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Cencora or Cosmos Health?
Cencora pays a dividend yielding 0.71%, while Cosmos Health does not currently pay a regular dividend.
Are Cencora and Cosmos Health in the same industry?
Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.